Katzung's Basic and Clinical Pharmacology. - 16th Edition - London | McGraw Hill LLC | 2023. - Page count:1,360

The most comprehensive and authoritative pharmacology text—updated with new content and USMLE-style questions

Presented in full-color and packed with hundreds of illustrations, Katzung's Basic and Clinical Pharmacology is the wide-ranging, engaging guide students have counted on for decades. To be as clinically relevant as possible, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects, along with case studies that introduce clinical problems.

Each chapter opens with a case study, covers drug groups and prototypes, and closes with summary tables and diagrams that encapsulate important information. Updated to reflect the latest research, this sixteenth edition features a new chapter on cannabinoids, USMLE-style questions, new drug tables, and more.

Katzung's Basic and Clinical Pharmacology, Sixteenth Edition features:

330 full-color illustrations 100 drug tables 50 USMLE-style questions Chapter on cannabinoids A strong emphasis on drug groups and prototypes Case studies and chapter-ending summary tables Organization that reflects the syllabi of pharmacology courses Descriptions of important new drugs

ISBN: 9781260463316 1260463311 = ACE inhibitors acetylcholine acid action potential activity acute administration adrenoceptors adverse effects agents agonist alcohol anesthesia anesthetic angina angiotensin antagonists antimuscarinic antipsychotic antiseizure arrhythmias arterial associated asthma benzodiazepines binding block blockade blood pressure calcium channel carbamazepine cardiac cardiovascular cause cells Chapter chronic clinical CNS concentration coronary decrease depolarization disease disorders diuretics dopamine dosage dose drugs duration efficacy eg enzyme excreted Figure function GABA gene half-life heart failure heart rate hepatic histamine hypertension hypotension increased inhaled inhibition inhibitors Interactions intravenous kidney levodopa liver loop diuretics mediated medications membrane metabolism metabolites mg mg/d molecule muscarinic myocardial nerve nervous system neuromuscular neurons nicotinic norepinephrine occur oral oxide pathways patients peptide peripheral Pharmacokinetics pharmacology phenytoin plasma potassium propofol protein pulmonary receptors reduce release renal renin response result risk seizures serotonin smooth muscle sodium channels stimulation symptoms synaptic syndrome therapeutic therapy thiazide tion tissue toxicity treatment trials vascular vasodilation ventricular verapamil α β

Subjects--Personal Names: --Medical / Pharmacology, Clinical pharmacology, Life sciences, Medical personnel, Pharmacology, Pharmacology, Clinical.